Line 272: | Line 272: | ||
</div> | </div> | ||
<div class="mainbody"> | <div class="mainbody"> | ||
− | In order to ensure the biosecurity of our project, we used piGEM2019-03 to accomplish our purpose. First of all, we tested the lysin gene Lysep3-D8 separately, by inserting it into an expression vector induced by IPTG (final concentration is 0.5mM) [5] [6]. Transformed it into <i>E.coli</i> BL21 (DE3). And we measured the growth curve to represent intracellular cleavage effect (Fig. 12). As Fig. | + | In order to ensure the biosecurity of our project, we used piGEM2019-03 to accomplish our purpose. First of all, we tested the lysin gene Lysep3-D8 separately, by inserting it into an expression vector induced by IPTG (final concentration is 0.5mM) [5] [6]. Transformed it into <i>E.coli</i> BL21 (DE3). And we measured the growth curve to represent intracellular cleavage effect (Fig. 12). As Fig. 12 shown, the Lysep3-D8 protein inhibited the growth of <i>E.coli</i> BL21, and the inhibition rate was about 30.7%. The Lysep3-D8 protein can only inhibit the growth but can’t kill it. |
</div> | </div> | ||
<div class="picture"> | <div class="picture"> |
Revision as of 01:03, 21 October 2019
Pathway construction
No. | Vector | E.coli resistance | Description |
---|---|---|---|
1 | piGEM2019-01 | Amp | PtisAB+LuxI+GFP+AmpR+ori+J23119+qnrS1 |
2 | piGEM2019-02 | Kan | PLuxR+PelB-5D+CrpP+TagRFP+J23100+LuxR+KanR+p15Aori |
3 | piGEM2019-03 | Amp | J23100+YF1+FixJ+Ter+PFixK2+Lysep3-D8+Ter+AmpR+ori |
(a) piGEM2019-01 digested by XbaⅠ+VspⅠ (lane 1), piGEM2019-01 digested by SalⅠ+VspⅠ (lane 2);
(b) piGEM2019-02 digested by SalⅠ+KpnⅠ (lane 1), piGEM2019-01 digested by HindⅢ+SacⅠ (lane 2);
(c) piGEM2019-03 digested by NdeⅠ+BamHⅠ (lane 1).
Ciprofloxacin detection
qnrS1--CIP resistance gene
E.coli DH5α carrying piGEM2019-01 was used to detect ciprofloxacin and produce AHL to activate piGEM2019-02. In order to achieve the better detection function, our detection bacteria must survive in a relatively high concentration of CIP. So, we added a ciprofloxacin resistance gene—qnrS1. We tested qnrS1 by adding gradient concentrations of CIP and measuring the growth curve (Fig. 2).
Moreover, we defined the Relative Bacterial Density to represent the resistance ability of qnrS1. The higher the Relative Bacterial Density is, the stronger the resistance will be. When the value was less than 1, it meant that the growth was suppressed. And we chose a significant concentration 1mg/L to represent the growth situation (Fig. 3). It could be seen intuitively from Fig. 3 that E.coli DH5α carrying piGEM2019-01 grew normally. Meanwhile, the values of negative control were all less than 1. It could be concluded that qnrS1 enhanced the viability of E.coli DH5α carrying piGEM2019-01 in CIP.
PtisAB--CIP responding promoter
Whether piGEM2019-01 actually has detection function depends on whether PtisAB responds to CIP. Fluorescence intensity was tested at different CIP concentrations every two hours (Fig. 4) [1]. The results showed that the fluorescence intensity in E.coli DH5α carrying piGEM2019-01 was significantly stronger than negative control.Besides, we could infer the concentration of ciprofloxacin from the green fluorescence intensity. At a concentration of 0-1mg/L of ciprofloxacin, its relationship with green fluorescence intensity is basically in accordance with y = 0.3698x + 0.5477. R2 = 0.9721. Where y is the green fluorescence intensity and x is the ciprofloxacin concentration.
Ciprofloxacin Degradation
Detection of CIP by HPLC
Considering the sensitivity and accuracy of High Performance Liquid Chromatography (HPLC), we chose it to monitor the degradation of CIP by CrpP. However, during our experiment, we found that the concentration of CIP inferred from the Km and Vmax given by Víctor M. Chávez-Jacobo., et al. (2018) [2] (~ 150 mg/L) is beyond the response range of our UV detector, so we had to low down the concentration of CIP. Therefore, we first need to establish a standard curve of ciprofloxacin concentration for the follow-up verification of the CIP-degrading function of CrpP enzyme.A standard curve of 50-300 μg/L ciprofloxacin was established by HPLC (Fig. 6) as a protocol described [3]. Within this range, the CIP concentration and the peak area shows a good linear relationship.
Degradation of CIP by CrpP
Then we co-transformed piGEM2019-01 and piGEM2019-02 into E.coli DH5α, and transformants were selected on LB agar plates using ampicillin and kanamycin. Overnight cultures of E. coli DH5α(piGEM2019-01 + piGEM2019-02) were diluted at a 1:100 ratio into 25 mL of fresh LB medium and were cultured at 37°C. When the culture was shaked for 1.5 hours, we added 1 mg/L CIP to induce the expression of CrpP, and the culture was incubated for additional 12 hours. Cells were harvested by centrifugation, and the pellets were suspended in 5mL PBS Buffer (pH=7.4). Then the mix was treated with sonication. We used the cell extracts to degrade CIP, but it was difficult to tell the difference between experimental group (CrpP+, E.coli express CrpP enzyme) and control group (CrpP-, E.coli without crpP gene) directly through peak shape in such a low CIP concentration.In order to solve the problem mentioned above, statistics methods were introduced. Same concentration of CIP was incubated in a 1.9mL mix including 2 mM ATP, with or without cell extracts that contain CrpP, at 37℃ for 30 minutes. Our experimental group (CrpP+) has 30 samples and control group (CrpP-) has 6 samples. Reaction was terminated by adjusting pH to about 2 (by adding Concentrated Hydrochloric Acid). It is reasonable to reckon that the average concentration of CIP of both group has no difference in the beginning, but we can clearly notice that the experimental group’s average concentration is lower than that of control group (Fig. 7). Moreover, T-test for comparison of pooled data mean was introduced to analyze our results. T-test results (P=0.036) indicate that in the case of a probability of error of less than 5%, there is a significant difference between the experimental group (CrpP+) and the control group (CrpP-). Thus, we can come to the conclusion that CrpP has the capability of degrading CIP.
Expression verification of CrpP
Although we used statistical methods to test the function of CrpP, we did not get the desired effect directly, so we decided to verify the expression of CrpP. We treated E.coli DH5α (piGEM2019-01 + piGEM2019-02) as section Degradation of CIP by CrpP described, and SDS-PAGE was selected to monitor the expression of CrpP. But from the result (Fig. 8a), we could only see the band of TagRFP, indicating that the expression system was working. But we couldn’t distinguish which one was the band of CrpP (CrpP expression quantity is low). In order to make CrpP better express so as to be able to be detected, we inserted pelB-5D, CrpP and TagRFP into an IPTG induced vector (pEASY) and transformed it into E.coli BL21 (DE3). More CrpP protein would been obtained by IPTG induction, and the concentration of IPTG was 0.5mM. As shown in Fig. 8b, there were obvious bands around 17kDa in the induction group. The results indicated that CrpP was successfully expressed in E.coli BL21 (DE3) induced by IPTG.CrpP activity by coupled enzymatic assay
After CrpP was expressed in E.coli BL21 (DE3), we used a coupled enzymatic assay involving NADH oxidation to measure the activity of crude enzyme on CIP, as described by Víctor M. Chávez-Jacobo [2]. NADH oxidation rate of the experimental group (IPTG+) , the control group (IPTG-) and the blank group are shown in Fig. 9. The blank group only uses PBS buffer solution. The experimental (control) group is cell disruption solution induced with (without) 0.5 mM IPTG. Our experimental data illustrates that, in the presence of CrpP, NADH oxidation increases with the reaction time, showing that CrpP can indeed degrade CIP.Quorum sensing system
Next, we wanted to verify quorum sensing using co-transformed E.coli DH5α. CIP was added to the experimental group, but not to the control group. After the same time, the bacterial liquid in the experimental group turned red, indicating that TagRFP was normally expressed, while the control group did not express TagRFP (Fig. 10). Based on this result, we can verify that AHL produced by piGEM2019-01 can normally activate the expression of piGEM2019-02. This proves that our quorum sensing system can work normally.Immobilization of bacteria
In addition, we mixed the E.coli bacteria solution carrying piGEM2019-02 with sodium alginate solution, and dropped the mixture into CaCl2 through the needle (Fig. 11) [4]. We successfully embedded the bacteria that could degrade CIP and immobilized the bacteria.Kill switch
From the above results, the Lysep3-D8 protein induced by IPTG strong inducer has the effect of inhibiting growth. Combined with the second safety mechanism-UV sterilization mechanism, we have minimized the risk of leakage of engineered bacteria and made the biosafety of the hardware a strong guarantee.
Improve our ciprofloxacin disposal system
1. Enhance the enzyme activity of CrpPAccording to the references, the Km of CrpP is relatively high, indicating the affinity is weak. So, we want to enhance the enzyme activity by site-directed mutation or other methods. As CrpP is a new discovered enzyme, there is a lot of space for improvement.
2. Optimize the expression system
As we want more CrpP enzyme to express, we can enhance PtisAB's response to CIP or just choose a stronger quorum sensing system to enable the expression quantity.
Improve our hardware
Our device is working normally at present, and we want it to be useful at more situations. In future, we can make some improvements to it so that it can be used to degrade other kinds of antibiotics, and this will help a lot in dealing with the abuse of antibiotics. Besides, it can be better used in larger scenarios, such as sewage plant, laboratory wastewater treatment or pharmaceutical wastewater treatment and so on after our late transformation.Enhance safety system
As for further experiments, it’s important for us to improve the function of blue-sensitive promoter and lysin protein. Match the darkroom and ultraviolet light in the device to prevent the escape of engineered bacteria, providing a double guarantee for the biosafety of our project.[2]Chávez-Jacobo, V. M., Hernández-Ramírez, K. C., Romo-Rodríguez, P., et al. (2018). CrpP is a novel ciprofloxacin-modifying enzyme encoded by the Pseudomonas aeruginosa pUM505 plasmid. Antimicrobial agents and chemotherapy, 62(6), e02629-17.
[3]China Medical Science and Technology Press. (2015). Pharmacopoeia of the People's Republic of China, Volume 2. Beijing.
[4]Cho, E., Jang, G., Kim, D., & Lee, T. S. (2017). Fabrication of hollow-centered sodium-alginate-based hydrogels embedded with various particles. Molecular Crystals and Liquid Crystals, 659(1), 71-76.
[5]Wang, G., Lu, X., Zhu, Y., et al. (2018). A light-controlled cell lysis system in bacteria. Journal of industrial microbiology & biotechnology, 45(6), 429-432.
[6]Wang, S., Gu, J., Lv, M. et al. (2017). The antibacterial activity of E. coli bacteriophage lysin lysep3 is enhanced by fusing the Bacillus amyloliquefaciens bacteriophage endolysin binding domain D8 to the C-terminal region. Journal of Microbiology, 55: 403.